Frequently Asked Questions
The global peripheral artery disease market was valued at USD 3.9 Billion in 2022.
The peripheral artery disease market is expected to grow at a CAGR of 8.80% between 2023 and 2030, reaching USD 7.0 Billion in 2030.
Hospitals have a market share of approximately 60.4% in 2022.
The oral segment is the market’s most popular and in-demand segment.
the catheter segment is anticipated to expand at a rapid CAGR.
North America will command a share of almost 40% of the market for Peripheral Artery Disease market (PAD)
The top players include Bayer AG, Abbott, Boston Scientific Corporation and BIOTRONIK. Other major players include AngioDynamics, Koninklijke Philips NV, Cook, Medtronic and Cardinal Health.
Increased Geriatric Population and Better Insurance and Reimbursement Policies are the major market drivers.
Treatment is costly, and there is underdiagnosis and a lack of awareness are the major market restraints.
Increasing desire for non-invasive treatment options and advancements in medical technology are the major opportunities in the peripheral artery disease industry.